It is not approved by the FDA, EMA, TGA, or any other regulatory authority
They also found a higher presence of Clostridiaceae bacteria in BD patients, with Collinsella specifically enriched in individuals with BD-II compared to those with BD-I, suggesting that different BD subtypes may have distinct microbiome patterns (McIntyre et al., 2021)
Without intervention, 20-30% could be muscle
Common side effects: These include nausea, diarrhea, and, in rare cases, more serious digestive complications
Rx are up to a medical providers discretion
Bariatric procedures or surgery were go-to options for many people prior to GLP-1 medications